• Posted On: April 28, 2024
• Posted By: simplicity

Company Announcement

Today, we are excited to share another major milestone in DiagnosticON’s journey toward transforming hospital care.
DiagnosticON has been officially selected to participate in the GIST Balkans Program 2024, a prestigious initiative supported by the U.S. Department of State to empower promising healthcare and technology startups across the Balkans.

The GIST Balkans Program is renowned for supporting startups that are innovating at the intersection of science, technology, and entrepreneurship.
Our selection for this program is a strong validation of DiagnosticON’s unique approach to AI-driven risk assessment and hospital readmission management.

By participating in the GIST Balkans Program, DiagnosticON will benefit from:

• Global Mentorship and Networking: Access to top international healthcare, policy, and startup mentors who will guide our expansion and scaling efforts.
• Investor and Market Access: Opportunities to connect with healthcare investors, hospital networks, and industry partners across Europe and the U.S.
• Specialized Training: Focused workshops and one-on-one sessions on market entry strategies, healthcare compliance, and global scaling best practices.

Being part of the GIST Balkans Program accelerates our mission to reduce preventable hospital readmissions and optimize discharge planning worldwide.
It also reinforces our commitment to applying cutting-edge science and AI in ways that directly benefit patients, hospitals, and healthcare systems.

We extend our sincere gratitude to our incredible team, advisors, and all those who continue to support our vision.
The future of DiagnosticON is global, and this achievement marks an important step in shaping smarter, more sustainable healthcare.

For more information about our journey with the GIST Balkans Program and our future plans, please contact us at office@diagnosticon.ai.